ZANNETTI, BEATRICE ANNA
 Distribuzione geografica
Continente #
NA - Nord America 1.353
EU - Europa 858
AS - Asia 415
AF - Africa 74
Totale 2.700
Nazione #
US - Stati Uniti d'America 1.343
GB - Regno Unito 226
SE - Svezia 157
CN - Cina 152
IT - Italia 145
DE - Germania 115
VN - Vietnam 113
SG - Singapore 84
IN - India 45
IE - Irlanda 40
FR - Francia 36
UA - Ucraina 34
RU - Federazione Russa 31
TG - Togo 23
CI - Costa d'Avorio 22
ZA - Sudafrica 22
EE - Estonia 17
BE - Belgio 15
BG - Bulgaria 15
FI - Finlandia 11
CA - Canada 10
JO - Giordania 8
CH - Svizzera 6
NG - Nigeria 6
JP - Giappone 4
IR - Iran 3
ES - Italia 2
LB - Libano 2
NL - Olanda 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
CZ - Repubblica Ceca 1
HU - Ungheria 1
KR - Corea 1
LV - Lettonia 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
SC - Seychelles 1
TR - Turchia 1
Totale 2.700
Città #
Southend 207
Chandler 176
Fairfield 170
Ashburn 119
Ann Arbor 94
Woodbridge 92
Wilmington 81
Seattle 78
Singapore 66
Houston 65
Cambridge 53
Princeton 46
Dublin 40
Bologna 36
Dong Ket 34
Lomé 23
Abidjan 22
New York 21
Westminster 21
Beijing 19
Jinan 19
Padova 19
Bremen 17
Nanjing 16
Brussels 15
Sofia 15
Berlin 14
Jacksonville 14
Florence 13
Turin 12
Helsinki 11
Redwood City 11
Saint Petersburg 11
Santa Clara 11
Changsha 10
San Diego 9
Shenyang 9
Amman 8
Los Angeles 8
Rome 8
Boardman 7
Hyderabad 7
Jiaxing 7
Milan 7
Nanchang 7
Abeokuta 6
Dearborn 6
Paris 6
Toronto 6
Falls Church 5
Hebei 5
Zhengzhou 5
Bern 4
Medford 4
Monmouth Junction 4
Mülheim 4
Tianjin 4
Washington 4
Imola 3
Kuban 3
Leawood 3
Munich 3
Tokyo 3
Andover 2
Bari 2
Forlì 2
Frankfurt am Main 2
Genoa 2
Groningen 2
Guangzhou 2
Haikou 2
Hockenheim 2
London 2
Mountain View 2
Naples 2
Ningbo 2
Norwalk 2
Nuremberg 2
Ottawa 2
Porto Recanati 2
Pune 2
Redmond 2
Romainville 2
Shanghai 2
Shijiazhuang 2
Taiyuan 2
Taizhou 2
Winnipeg 2
Acton 1
Budapest 1
Buffalo 1
Casalecchio di Reno 1
Changchun 1
Chaowai 1
Chengdu 1
Chicago 1
Dalian 1
Dallas 1
Des Moines 1
Dongguan 1
Totale 1.888
Nome #
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease 210
Bortezomib-based therapy combined with high cut-off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment 192
Peripheral neuropathy induced by subcutaneous bortezomib-based induction therapy for newly diagnosed multiple myeloma. 180
Positron emission tomography with computed tomography-based diagnosis of massive extramedullary progression in a patient with high-risk multiple myeloma. 169
Bortezomib and dexamethasone as salvage therapy in patients with relapsed/refractory multiple myeloma: analysis of long-term clinical outcomes 169
Current and emerging triplet combination therapies for relapsed and refractory multiple myeloma 135
Safety and efficacy of daratumumab in dialysis-dependent renal failure secondary to multiple myeloma 129
Opposite activation of the Hedgehog pathway in CD138+ plasma cells and CD138-CD19+ B cells identifies two subgroups of patients with multiple myeloma and different prognosis 127
Prognostic impact of serial measurements of serum-free light chain assay throughout the course of newly diagnosed multiple myeloma treated with bortezomib-based regimens 126
Very Poor Outcome and Chemoresistance of Acute Myeloid Leukemia Patients with TP53 Mutations: Correlation with Complex Karyotype and Clinical Outcome 120
Role of serum free light chain assay in the detection of early relapse and prediction of prognosis after relapse in multiple myeloma patients treated upfront with novel agents 118
Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma 116
HIF-1α inhibition blocks the cross talk between multiple myeloma plasma cells and tumor microenvironment 114
PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma 112
Long-term follow-up after autologous stem cell transplantation for light- and heavy-chain deposition disease. 107
Multiple myeloma, venous thromboembolism, and treatment-related risk of thrombosis. 107
Long-term results of thalidomide and dexamethasone (thal-dex) as therapy of first relapse in multiple myeloma. 106
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma 100
Gene expression analysis of newly diagnosed Multiple Myeloma (MM) patients carrying amplified MDM4 and/or deleted p5 95
TP53 mutations are mutually exclusive with FLT3 and NPM mutations in AML patients and are strongly associated with complex karyotype and poor outcome 91
SIRT Regulates the Molecular Interaction Between c-MYC and HIF-1α in Multiple Myeloma 89
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma 28
New Horizons in Immunology and Immunotherapy of Acute Leukemias and Related Disorders 15
Novel insights and therapeutic approaches in secondary AML 13
Multiple Myeloma: The Role of Autologous Stem Cell Transplantation in the Era of Immunotherapy 10
Overview on novel strategies and current guidelines for hematopoietic stem cell mobilisation and collection 4
Totale 2.782
Categoria #
all - tutte 7.039
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.039


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020588 0 0 0 40 71 69 86 97 86 55 37 47
2020/2021358 67 26 11 10 15 23 14 20 39 17 17 99
2021/2022520 67 25 26 47 47 19 6 34 13 53 86 97
2022/2023611 54 97 26 97 41 57 11 37 108 15 47 21
2023/2024199 15 23 12 25 16 63 13 9 1 8 6 8
2024/2025191 32 91 54 14 0 0 0 0 0 0 0 0
Totale 2.782